Therapy Areas: Oncology
Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients with Rare and Complex Conditions
22 March 2019 - - US-based specialty pharmacy Biologics by McKesson is expanding its capabilities as a specialty pharmacy expert in oncology and complex conditions through a new exclusive distrib...
Sanofi Starts Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis, Triggering Milestone Payment to Lead Pharma
22 March 2019 - - Dutch pharmaceutical company Lead Pharma has achieved a fourth milestone under its license and collaboration agreement with French drugmaker Sanofi (NYSE: SNY), triggering an undiscl...
Samsung Bioepis Releases Three-year Follow-up Data for Biosimilar Ontruzant in Early or Locally Advanced HER2-positive Breast Cancer
22 March 2019 - - South Korea-based Samsung Bioepis Co., Ltd has received findings of a three-year follow-up study comparing biosimilar Ontruzant (trastuzumab) and reference medicine trastuzumab in ea...
Imago BioSciences Raises USD 40m Series B Financing Led by Omega Funds
22 March 2019 - - US-based clinical-stage biotechnology company Imago BioSciences, Inc has secured USD 40m series B financing led by Omega Funds, a international investment firm that creates and inves...
LegoChem Biosciences partners with Takeda for development of antibody-drug conjugates in immuno-oncology
22 March 2019 - Biopharmaceutical company LegoChem Biosciences Inc (KOSDAQ:141080) said on Friday that it plans to develop antibody-drug conjugates in immuno-oncology through a research collaboration ...
Hansa Biopharma selects lead candidate from NiceR programme
22 March 2019 - Hansa Biopharma AB (STO:HNSA), a provider of immunomodulatory enzyme technology for rare IgG-mediated diseases, announced on Thursday the selection of a lead candidate for clinical dev...
Related Headlines

Forma Therapeutics Names Lee as Chief Executive Officer

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute

Aura to Present Interim Phase 1b/2 Clinical Data for AU-011 at the International Society of Ocular Oncology 2019 Annual Meeting

Transgene Secures a EUR 20m Revolving Credit Facility with Natixis

Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer

FDA Approves Genentech's Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer

Bicycle Therapeutics Names Legault as New Director and Board Chairman

NeoPhore names new non-executive director

Merck KGaA and Pfizer discontinue ovarian cancer drug trial

Puma Viotechnology's Licensing Partner Specialised Therapeutics Asia Receives Regulatory Approval to Commercialize Nerlynx for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of Farxiga in Type 2 Diabetes

CSI Laboratories Begins offering Ventana PD-L1 (SP142) Assay as Companion Diagnostic Test for Triple Negative Breast Cancer as a Result of FDA Approval for Tencentriq

Cold Genesys Closes USD 22m Series C Financing

Bicycle Therapeutics Names Legault as New Director and Board Chairman

Roche's Tecentriq chemotherapy combination granted FDA approval for the initial treatment of adults with extensive-stage small cell lung cancer